With a very limited number of genetic counselors nationwide, it’s impossible for every fertility patient to see one. Clinics like RMA New York are getting strategic.

In this week’s episode of Inside Reproductive Health, genetic counselor Teresa Cacchione explains why genetic counseling in IVF is becoming increasingly critical and complex.

Teresa discusses:

• Why and how RMA-NY relies on a partner called GeneScreen Why even low-risk carrier results can confuse patients (and what to do about it)

• The growing demand for informed consent around PGT

• The risks of relying solely on lab panels

• How RMA decides which patients need in-house counseling

• The legal and ethical implications of not providing sufficient counseling before treatment